metformin
Commercial- Indications
- Aging, Diabetes prevention
Company intelligence / Profile preview
AgelessRx
- Ownership
- Private
- Employees
- ~74
- Development stage
- Commercial
01
Overview
Pioneering telehealth platform offering science-backed longevity therapies including Metformin, NAD+, LDN, and GLP-1 agonists through decentralized clinical models and direct-to-consumer delivery.
- Therapeutic areas
- Metabolic DisordersEndocrinologyNeurologyInfectious Diseases
- Modalities
- Small moleculesPeptide therapiesCompounded formulations
- Industry
- Non-Academic Healthcare
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Lifespan.io (PEARL Trial crowdfunding partner)
Beyond the preview
Go deeper on AgelessRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AgelessRx.